Expression Systems

What Expression Systems does

Expression Systems, LLC is a Davis, California-based specialty life sciences company founded in 1997 and acquired by ANGUS Chemical Company (now Advancion) in November 2022. The company supplies chemically defined and serum-free insect and mammalian cell culture media, proprietary insect cell lines (Sf9, Sf21, Tni, S2, and the biosafety-differentiated Sf9 RV-Free), mammalian cell lines (293-ES, CHO-ES), supporting reagents (Production Boost Additive, Transfection Medium), and contract services including baculovirus titering and CMO activities. Its underlying technology is the baculovirus expression vector system (BEVS) platform, where insect cells are used to produce recombinant proteins, virus-like particles, AAV vectors for gene therapy, and vaccines.

The company operates in a tightly regulated niche: its Davis facility is cGMP-compliant under 21 CFR Part 820 and ISO 13485:2016 certified, and ESF AF holds a Drug Master File with the US FDA — qualifications that make its media usable in clinical and commercial biomanufacturing. ESF 921 is described as the industry standard medium for BEVS applications, and the 2023-launched ESF AdvanCD is positioned as a next-generation chemically defined medium with claimed up to 2x cell growth capacity. Revenue is generated through unit-priced catalog media sales, cell line licensing (including commercial licenses for Sf9 RV-Free), titering services at $195 per sample, and CMO/contract services. Distribution combines direct e-commerce and phone ordering with a global distributor network covering North America, EMEA, Greater China, India, Japan, Korea, and Southeast Asia, increasingly operated through parent Advancion's regional commercial contacts. The customer base spans structural biology researchers in academia and biologics and AAV gene therapy developers in biotech and pharma.

Name

Expression Systems

Legal name

Expression Systems, LLC

Website

https://expressionsystems.com

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Expression Systems supplies chemically defined insect and mammalian cell culture media, proprietary cell lines (including Sf9 RV-Free), and baculovirus-based contract services for biologics, AAV gene therapy, vaccine, and structural biology customers globally, operating as a subsidiary of Advancion.

Ownership category

akta.pro rank

Product category

Cell Culture Media and Reagents

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

SIC

Biological Products, (No Disgnostic Substances) (2836), Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Gene Therapy CMC/Process Development Platforms (capsid engineering, producer cell lines, plasmids, upstream/downstream) (HLAAACAN)

akta.pro secondary industries

Gene Therapy Vector Manufacturing & CDMO Services (HLAAACAJ), Cell Banking & Viral Seed Services (MCB/WCB/VSB) (HLAGAGAD)

Keywords

• Insect cell culture
• Baculovirus expression
• Cell culture media
• Recombinant protein production
• Viral vector manufacturing

Headquarters

HQ city

Davis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Cell Culture Media Products: Sale of proprietary cell culture media formulations including ESF 921, ESF AF, ESF SFM, and ESF AdvanCD in various packaging sizes from 1L bottles to 50L media transfer bags.
2. Cell Lines and Licensing: Sale of proprietary insect and mammalian cell lines (Sf9, Sf21, Tni, S2, 293-ES, CHO-ES) with associated licensing for commercial applications. Sf9 RV-Free cell line requires commercial license agreement for clinical or commercial use.
3. Contract Services: Baculovirus titering service using flow cytometric analysis for accurate virus titer determination. CMO and contract manufacturing services for biologics production.
4. Reagents and Molecular Tools: Sale of supporting reagents including Production Boost Additive, Transfection Medium, Expres2 TR Transfection Reagent, and gp64-PE antibody for baculovirus workflows.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Expression Systems manufactures and supplies specialty cell culture media, proprietary cell lines, reagents and molecular tools built around the baculovirus expression vector system (BEVS) platform. Its core offerings include chemically defined and serum-free insect cell culture media (ESF 921, ESF AF, ESF AdvanCD) and mammalian cell culture media (ESF SFM), along with insect cell lines (Sf9, Sf21, Tni, S2, and the proprietary Sf9 RV-Free rhabdovirus-negative line) and mammalian cell lines (293-ES, CHO-ES). The company also provides baculovirus titering services and CMO/contract manufacturing services for biologics production.

Product overview

Expression Systems offers a comprehensive portfolio of insect and mammalian cell culture products centered on the baculovirus expression vector system (BEVS) platform. The core product line consists of chemically defined and serum-free cell culture media formulations: ESF 921 (protein-free insect medium), ESF AF (animal-free insect medium), ESF AdvanCD (next-generation chemically defined medium), and ESF SFM (mammalian cell medium). These are complemented by a selection of pre-adapted insect cell lines (Sf9, Sf21, Tni, S2), mammalian cell lines (293-ES, CHO-ES), and the proprietary Sf9 RV-Free rhabdovirus-negative cell line developed for enhanced biosafety. Supporting products include the Production Boost Additive for extending expression periods, Transfection Medium for vector production, and Baculovirus Titering Service for quality control. The company also provides CMO and contract services, while the parent company Advancion offers a complementary portfolio of biological buffers including TRIS AMINO and HEPES products. The portfolio serves structural biology researchers, biologics manufacturers, and gene therapy developers producing recombinant proteins, vaccines, virus-like particles, and AAV vectors.

Differentiator

Problem solved

Functional benefit

Brands

• ESF AdvanCD: A 100% chemically defined, animal-origin-free, protein-free, serum-free insect cell culture medium for viral vector manufacturing and structural biology applications.
• ESF AF
• ESF 921
• ESF SFM

Products and services

• ESF 921 Insect Cell Culture Medium

Quantifiable outcome

• Up to double the capacity for cell growth compared to other commercially available media
• +4 more outcomes

Named customers3 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Two partnerships are on record, tiered minor and core.

• ThomsonminorStrategic or Co-development Partner · 10 April 2023Expression Systems teamed up with Thomson to demonstrate how the combination of Expression Systems' ESF AdvanCD cell culture medium and Thomson Optimum Growth flasks offers an effective solution for scaling up protein production using baculovirus and insect cell expression platforms. The collaboration demonstrated highly consistent cell growth and exceptional expression levels between various flask sizes and culture volumes.
• Advancion (formerly ANGUS Chemical Company)coreStrategic or Co-development Partner · 9 November 2022Advancion (formerly ANGUS Chemical Company) acquired Expression Systems in November 2022 as an important step in expanding ANGUS' leadership position in Life Sciences beyond bio buffers into specialty cell culture media. The combination strengthens ability to deliver consistent, high-quality ingredients and services essential to all phases of bioprocessing.

Scale indicators4 records

Recent moves4 records

Expansion highlights6 records

Direct peers

• FUJIFILM Irvine Scientific: Specialized cell culture media and reagents provider serving cell and gene therapy, biologics manufacturing, and assisted reproductive technologies. Directly competes with Expression Systems in chemically defined and serum-free media formulations for advanced therapy manufacturing.
• CellGenix: Cell culture media and reagents provider specifically focused on cell and gene therapy and regenerative medicine manufacturing. Direct competitor in GMP-grade media for viral vector and cell therapy production, addressing the same customer base as Expression Systems.
• Corning Life Sciences: Corning offers cell culture media, sera, and bioprocess solutions including insect cell media and cell culture vessels. Direct competitor in cell culture media for biologics manufacturing with comparable product categories and target customers.

Broad incumbents

• Sartorius: Global bioprocess solutions leader offering cell culture media, bioreactors, and filtration through acquisitions including Biological Industries and BIA Separations. Overlaps with Expression Systems in cell culture media for biologics and gene therapy manufacturing as part of a much broader portfolio.
• Cytiva: A Danaher-owned bioprocess leader offering cell culture media, single-use technologies, and process development services. Competes broadly with Expression Systems in upstream bioprocessing media for biologics and advanced therapy manufacturing.
• Thermo Fisher Scientific: Largest life sciences tools company with Gibco brand cell culture media serving biologics, cell therapy, and gene therapy manufacturing. Operates at much greater scale than Expression Systems and is a major competitor in chemically defined and serum-free media.
• Lonza: Global CDMO and bioprocess solutions provider offering cell culture media, custom media development, and contract manufacturing services. Overlaps with Expression Systems in media formulations for biologics and offers direct competition in CMO services using baculovirus and other platforms.
• Merck KGaA (MilliporeSigma): Life sciences division offering cell culture media (Cellvento, EX-Cell), bioprocess solutions, and CDMO services through its BioReliance portfolio. Major incumbent competitor to Expression Systems in upstream bioprocessing for gene therapy and biologics manufacturing.

Emerging players

• BPS Bioscience: Specialized provider of recombinant proteins, cell lines, and assay services for life science research. Partial overlap with Expression Systems in cell lines and recombinant protein production using baculovirus and mammalian expression systems.
• ProteoGenix: Recombinant protein expression services and products company specializing in baculovirus/insect cell, mammalian, and E. coli expression systems. Directly comparable to Expression Systems in BEVS-based protein production services for research and biopharma customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Expression Systems